Thimble bioelectronics wearable ENSO could potentially help with neuropathy

Wearable for neuropathy pain relief

Thimble Bioelectronics ENSO device uses high-frequency impulse therapy (HFIT) to help patients manage chronic pain issues without the need for medicines or surgery.

The ENSO smartphone app lets you control your ENSO HFIT™ device and switch between multiple ENSO HFIT™ devices. The FDA has also cleared the device for the treatment of chronic pain.

Related Reading

How Thimble helps patients manage chronic pain issues without the need for medicines or surgery

According to the manufacturer, ENSO HFIT™ is a non-invasive device shown in double-blind clinical trials to reduce pain by 56% and deliver clinically effective relief for 86% of patients.

Thimble has also signed up with Harvard Medical school to study the impact of high-frequency impulse therapy for Neuropathic pain.

The National Institute of Neurological Disorders and Stroke (NINDS) reported that 20 million Americans have peripheral neuropathy.

This is a common problem for patients who have suffered a stroke, have diabetes, or undergone chemotherapy.

Current drugs help but often fail to offer relief for many patients

Today’s standard course of treatment for neuropathic pain is either Gabapentin or Pregabalin, and each of these drugs has its own side effects. 

This latest clinical study is being sponsored by Harvard Medical school with the collaboration of Thumble Bioelectronics.

Clinical study objectives

This latest clinical trial’s objective is to determine whether self-administered, at-home use of ENSO therapy, a high-frequency impulse neuromodulation device, is an effective, acceptable, and feasible method of relief from neuropathic pain among patients with Neuromyelitis Optica spectrum disorder (NMOSD).Thimble ENSO Wearable specs

Although there are many devices out there that provide transcutaneous electrical nerve stimulation (e.g., TENS unit), ENSO has evolved to be a leader in this space after working with different clinicians and proving their product via numerous clinical trials.

The possibility that users can manage chronic pain associated with Neuropathy by using a non-invasive wearable is definitely great news. Hopefully, it results in bringing both relief and hope to many patients who suffer from neuropathy.

Previous articlePeloton lowers price and not offering any Black Friday or Cyber Monday promotions for 2020
Next articleNew study examines using Apple Watch to monitor side effects of radiation therapy
I am a technologist with years of experience with Apple and wearOS products, have a BS in Computer Science and an MBA specializing in emerging tech, and owned the popular site AppleToolBox. In my day job, I advise Fortune 500 companies with their digital transformation strategies and also consult with numerous digital health startups in an advisory capacity. I'm VERY interested in exploring the digital health and fitness-tech evolution and keeping a close eye on patents, FDA approvals, strategic partnerships, and developments happening in the wearables and digital health sector. When I'm not writing or presenting, I run with my Apple Watch Ultra or Samsung Galaxy Watch and closely monitor my HRV and other recovery metrics.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.